These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34461556)

  • 1. Improving speech characteristics of young adults with congenital dysarthria: An exploratory study comparing articulation training and the Beatalk method.
    Icht M
    J Commun Disord; 2021; 93():106147. PubMed ID: 34461556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introducing the Beatalk technique: using beatbox sounds and rhythms to improve speech characteristics of adults with intellectual disability.
    Icht M
    Int J Lang Commun Disord; 2019 May; 54(3):401-416. PubMed ID: 30478972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Speech treatment for Hebrew-speaking adolescents and young adults with developmental dysarthria: A comparison of mSIT and Beatalk.
    Carl M; Levy ES; Icht M
    Int J Lang Commun Disord; 2022 May; 57(3):660-679. PubMed ID: 35363414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of boost articulation therapy (BArT) on intelligibility in adults with dysarthria.
    Mendoza Ramos V; Paulyn C; Van den Steen L; Hernandez-Diaz Huici ME; De Bodt M; Van Nuffelen G
    Int J Lang Commun Disord; 2021 Mar; 56(2):271-282. PubMed ID: 33484095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive effects of the Beatalk technique on speech characteristics of young adults with intellectual disability.
    Icht M; Carl M
    Int J Dev Disabil; 2023; 69(6):957-961. PubMed ID: 37885842
    [No Abstract]   [Full Text] [Related]  

  • 6. Acoustic changes in the speech of children with cerebral palsy following an intensive program of dysarthria therapy.
    Pennington L; Lombardo E; Steen N; Miller N
    Int J Lang Commun Disord; 2018 Jan; 53(1):182-195. PubMed ID: 28714530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes to articulation following LSVT(R) and traditional dysarthria therapy in non-progressive dysarthria.
    Wenke RJ; Cornwell P; Theodoros DG
    Int J Speech Lang Pathol; 2010 Jun; 12(3):203-20. PubMed ID: 20433339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electropalatography treatment for articulation impairment in children with dysarthria post-traumatic brain injury.
    Morgan A; Liegeois F; Occomore L
    Brain Inj; 2007 Oct; 21(11):1183-93. PubMed ID: 17896211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automatic boost articulation therapy in adults with dysarthria: Acceptability, usability and user interaction.
    Mendoza Ramos V; Vasquez-Correa JC; Cremers R; Van Den Steen L; Nöth E; De Bodt M; Van Nuffelen G
    Int J Lang Commun Disord; 2021 Sep; 56(5):892-906. PubMed ID: 34227721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A serious game for speech training in dysarthric speakers with Parkinson's disease: Exploring therapeutic efficacy and patient satisfaction.
    Ganzeboom M; Bakker M; Beijer L; Strik H; Rietveld T
    Int J Lang Commun Disord; 2022 Jul; 57(4):808-821. PubMed ID: 35338751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intelligibility as a clinical outcome measure following intervention with children with phonologically based speech-sound disorders.
    Lousada M; Jesus LM; Hall A; Joffe V
    Int J Lang Commun Disord; 2014; 49(5):584-601. PubMed ID: 24861159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of rate control on speech production and intelligibility in dysarthria.
    Van Nuffelen G; De Bodt M; Vanderwegen J; Van de Heyning P; Wuyts F
    Folia Phoniatr Logop; 2010; 62(3):110-9. PubMed ID: 20424466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An exploration of listener variability in intelligibility judgments.
    McHenry M
    Am J Speech Lang Pathol; 2011 May; 20(2):119-23. PubMed ID: 21317298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intelligibility, Articulation Rate, Fluency, and Communicative Efficiency in Typically Developing Children.
    Schölderle T; Haas E; Baumeister S; Ziegler W
    J Speech Lang Hear Res; 2021 Jul; 64(7):2575-2585. PubMed ID: 34232737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Be Clear: A New Intensive Speech Treatment for Adults With Nonprogressive Dysarthria.
    Park S; Theodoros D; Finch E; Cardell E
    Am J Speech Lang Pathol; 2016 Feb; 25(1):97-110. PubMed ID: 26882004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Intelligibility Gains in Individuals With Dysarthria From Baseline Speech Features.
    Fletcher AR; McAuliffe MJ; Lansford KL; Sinex DG; Liss JM
    J Speech Lang Hear Res; 2017 Nov; 60(11):3043-3057. PubMed ID: 29075753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Speech Treatment Effects on Narrative Intelligibility in French-Speaking Children With Dysarthria.
    Moya-Galé G; Keller B; Escorial S; Levy ES
    J Speech Lang Hear Res; 2021 Jun; 64(6S):2154-2168. PubMed ID: 33719503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of speech cues in French-speaking children with dysarthria.
    Levy ES; Moya-Galé G; Chang YM; Campanelli L; MacLeod AAN; Escorial S; Maillart C
    Int J Lang Commun Disord; 2020 May; 55(3):401-416. PubMed ID: 32077196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Speech therapy for children with dysarthria acquired before three years of age.
    Pennington L; Parker NK; Kelly H; Miller N
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD006937. PubMed ID: 27428115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of consonant articulation errors in dysarthric speech.
    Kim H; Martin K; Hasegawa-Johnson M; Perlman A
    Clin Linguist Phon; 2010 Oct; 24(10):759-70. PubMed ID: 20831376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.